The biotech market in the United States is experiencing a significant surge in need for Tirzepatide APIs. This powerful medication, used to treat type 2 diabetes, has attracted remarkable attention from both individuals and doctors. As a result, numerous firms have emerged as suppliers of Tirzepatid